Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · IEX Real-Time Price · USD

5.35

+0.35 (7.00%)

At close: Apr 25, 2024, 12:00 AM

4.820

-0.530 (-9.91%)

After-hours: Apr 26, 2024, 4:42 PM EDT

RGC Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	4.69	5.11	0.94	0.43	0.16
Research & Development	1.58	2.51	0.44	0.39	0.23
Operating Expenses	6.27	7.62	1.38	0.81	0.39
Operating Income	-6.27	-7.62	-1.38	-0.81	-0.39
Other Expense / Income	-0.4	-0.17	-0.03	-	-
Pretax Income	-5.87	-7.45	-1.35	-0.81	-0.39
Net Income	-5.87	-7.45	-1.35	-0.81	-0.39
Shares Outstanding (Basic)	13	13	10	10	10
Shares Outstanding (Diluted)	13	13	10	10	10
Shares Change	1.62%	28.06%	-	-	-
EPS (Basic)	-0.45	-0.58	-0.13	-0.08	-0.04
EPS (Diluted)	-0.45	-0.58	-0.13	-0.08	-0.04
Free Cash Flow	-4.99	-6.05	-0.77	-0.84	-0.39
Free Cash Flow Per Share	-0.38	-0.47	-0.08	-0.08	-0.04
EBITDA	-5.1	-6.84	-1.32	-0.8	-0.39
Depreciation & Amortization	0.77	0.6	0.03	0.01	0
EBIT	-5.87	-7.45	-1.35	-0.81	-0.39

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).